Who
John A. McCoy Jr.
Vice President and Controller
Company insider
Files Form 4 as: Vice President and Controller, Abbott Laboratories; SVP and Controller, Baxalta.
In numbers
- Trades disclosed
- 50
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $278K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 1 Jul 2015
- Last trade
- 2 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Sep 2026filed 3 Sep 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Sold | $2,95827 at $109.54 | filing |
| 2 Sep 2026filed 3 Sep 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Sold | $2,95827 at $109.54 | filing |
| 1 Sep 2026filed 3 Sep 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $5,73952 at $110.36 | filing |
| 1 Sep 2026filed 3 Sep 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $5,73952 at $110.36 | filing |
| 2 Mar 2026filed 3 Mar 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Sold | $68K585 at $115.58 | filing |
| 2 Mar 2026filed 3 Mar 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Sold | $68K585 at $115.58 | filing |
| 27 Feb 2026filed 3 Mar 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $133K1,142 at $116.26 | filing |
| 27 Feb 2026filed 3 Mar 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $133K1,142 at $116.26 | filing |
| 24 Feb 2026filed 26 Feb 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —5,373 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,151 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,151 at $0.00 | filing |
| 24 Feb 2026filed 26 Feb 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —5,373 at $0.00 | filing |
| 1 Sep 2025filed 3 Sep 2025 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $10K79 at $132.66 | filing |
| 3 Mar 2025filed 4 Mar 2025 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Sold | $78K562 at $138.17 | filing |
| 28 Feb 2025filed 4 Mar 2025 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $149K1,096 at $135.87 | filing |
| 25 Feb 2025filed 27 Feb 2025 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,040 at $0.00 | filing |
| 25 Feb 2025filed 27 Feb 2025 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —4,038 at $0.00 | filing |
| 4 Sep 2024filed 4 Sep 2024 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Sold | $3,10027 at $114.83 | filing |
| 1 Sep 2024filed 4 Sep 2024 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $5,89052 at $113.27 | filing |
| 1 Mar 2024filed 4 Mar 2024 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Sold | $56K472 at $118.50 | filing |
News
Abbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy?ABT · fool.com · 24 Oct 2026Tag: abbott_laboratories_settlementABT · newsroomamerica.com · 24 Oct 2026Abbott Laboratories announces a baby formula spinoff companyABT · marketplace.org · 21 Oct 2026
0 headlines in the last 90 days name John A. McCoy Jr.; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.